Literature DB >> 21652584

Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review.

Gary J Macfarlane1, Ashraf El-Metwally, Vijitha De Silva, Edzard Ernst, Gillian L Dowds, Robert J Moots.   

Abstract

OBJECTIVE: To critically evaluate the evidence regarding complementary and alternative medicine (CAM) taken orally or applied topically (excluding fish oil) in the treatment of RA.
METHODS: Randomized controlled trials (RCTs) of RA using CAMs, in comparison with other treatments or placebo, published in English up to August 2010, were eligible for inclusion. They were identified using systematic searches of bibliographic databases and manual searching of reference lists. Information was extracted on outcomes and statistical significance, in comparison with alternative treatments, and reported side effects. The methodological quality of the primary studies was determined using the Jadad scoring system.
RESULTS: Reported RCTs were available for 18 CAMs in the management of RA. There was no consistent evidence available for any of the reviewed substances to suggest that they were efficacious as complementary medicines to standard treatment. Nevertheless, the studies conducted on borage seed oil (n = 2) and thunder god vine (n = 3) have been positive and may warrant further investigation. Not all CAM compounds studied were free of major adverse effects.
CONCLUSION: The major limitation in reviewing the evidence for CAMs is the paucity of RCTs in the area. The available evidence does not support their current use in the management of RA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652584     DOI: 10.1093/rheumatology/ker119

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

Review 1.  Clinical potential of antigen-specific therapies in type 1 diabetes.

Authors:  Ken T Coppieters; Birgit Sehested Hansen; Matthias G von Herrath
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  Prospective clinical trial examining the impact of genetic variation in FADS1 on the metabolism of linoleic acid- and ɣ-linolenic acid-containing botanical oils.

Authors:  Susan Sergeant; Brian Hallmark; Rasika A Mathias; Tammy L Mustin; Priscilla Ivester; Maggie L Bohannon; Ingo Ruczinski; Laurel Johnstone; Michael C Seeds; Floyd H Chilton
Journal:  Am J Clin Nutr       Date:  2020-05-01       Impact factor: 7.045

3.  Cannabis for pain in orthopedics: a systematic review focusing on study methodology

Authors:  Kim Madden; Annie George; Niek J. van der Hoek; Felipe Moreira Borim; George Mammen; Mohit Bhandari
Journal:  Can J Surg       Date:  2019-12-01       Impact factor: 2.089

Review 4.  A critical review of complementary and alternative medicine use among people with arthritis: a focus upon prevalence, cost, user profiles, motivation, decision-making, perceived benefits and communication.

Authors:  Lu Yang; David Sibbritt; Jon Adams
Journal:  Rheumatol Int       Date:  2016-11-26       Impact factor: 2.631

Review 5.  Complementary and alternative medicine in rheumatoid arthritis.

Authors:  S Chandrashekara
Journal:  Chin J Integr Med       Date:  2011-10       Impact factor: 1.978

Review 6.  Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes.

Authors:  Susan Sergeant; Elaheh Rahbar; Floyd H Chilton
Journal:  Eur J Pharmacol       Date:  2016-04-12       Impact factor: 4.432

7.  Natural Product Dietary Supplement Use by Individuals With Rheumatoid Arthritis: A Scoping Review.

Authors:  Janel C DeSalvo; Meghan B Skiba; Carol L Howe; Karen E Haiber; Janet L Funk
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-05-03       Impact factor: 4.794

Review 8.  Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients.

Authors:  Sizheng Zhao; Fred Otieno; Asan Akpan; Robert J Moots
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

Review 9.  Trials in type 1 diabetes: Antigen-specific therapies.

Authors:  Ken T Coppieters; Leonard C Harrison; Matthias G von Herrath
Journal:  Clin Immunol       Date:  2013-02-15       Impact factor: 3.969

10.  Complementary and alternative medicine use in African Americans with rheumatoid arthritis.

Authors:  Ashutosh Tamhane; Gerald McGwin; David T Redden; Laura B Hughes; Elizabeth E Brown; Andrew O Westfall; Doyt L Conn; Beth L Jonas; Edwin A Smith; Richard D Brasington; Larry W Moreland; S Louis Bridges; Leigh F Callahan
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-02       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.